BackTable Urology

Thin-slice CT after ureteroscopy tells an uncomfortable story: a lot of stone gets left behind.

Dr. Ruchika Talwar (@RuchikaTalwarMD) opens with Dr. Karen Stern (@KSternAZ) on why the field is rethinking the operation, how fast the technology has moved since residency, and why success means something different for a patient who wants a perfectly clean CT than for one who wants a few years without a stone episode and no stent. They also retire the old dusting versus fragmenting camps in favor of an approach built around the patient.

Watch the full episode here:
backtable.com/shows/urology/…

This podcast is supported by Dornier. (@DornierMedTech)

#URO337 #Ureteroscopy #KidneyStones #Endourology #StoneFree #Urology @MayoUrology @VUMCDiscoveries

Up three or four times a night and every 45 minutes by day is a 24-hour problem, not just nocturia.

Dr. Bilal Chughtai (@ChughtaiMD) and Dr. Anjali Kapur (@anjalikapurmd) on sorting OAB, BPH, and sleep apnea in men.

This podcast is supported by Sumitomo Pharma America, Inc.

Watch the full episode on the BackTable App:
backtable.com/shows/urology/…

#URO341 #OveractiveBladder #OAB #BPH #Nocturia @NorthwellHealth @AmerUrological @NYUUrology

We’ve got a surprise guest coming to the #BackTablePodcast. 👤

@RuchikaTalwarMD is taking off her clinical hat to talk about the business side of healthcare.

Any guesses who it might be? Drop your guess in the comments below. 👇

🎧 Dropping November 12 on BackTable Urology and BackTable Industry.

#BackTable #DirectContracting #HealthcareBusiness

Sooner or later the genomic report and the NCCN risk group point in opposite directions, and there is no guideline paragraph that tells you which one to follow.

Dr. Angela Jia (@angela_jia_) gives Dr. Ruchika Talwar (@RuchikaTalwarMD) her approach to both directions of discordance, working through a grade group 1 cancer with a convincing PI-RADS 5 lesion and a very high genomic score, and then a high-risk patient facing eighteen to twenty-four months of hormone therapy he does not want.

Watch the full episode here:
backtable.com/shows/urology/…

This podcast is supported by Veracyte.

#URO336 #ProstateCancer #ActiveSurveillance #AndrogenDeprivationTherapy #GenomicClassifier #UrologicOncology @RadOncUH @UHhospitals @ASTRO_org

“Son, have you ever had a cystoscopy?”

A patient’s question sums up why intermediate-risk bladder cancer care should be judged by quality of life.

Dr. Wesley Yip (@WesleyYipMD) of City of Hope (@cityofhope) and Dr. Ruchika Talwar (@RuchikaTalwarMD) on rethinking intermediate-risk NMIBC.

Watch the full episode on the BackTable App:
backtable.com/shows/urology/…

#URO340 #BladderCancer #NMIBC #Urology #Cystoscopy @AmerUrological @VUMCDiscoveries